Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

NCT00308412 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Paramyxoviridae Infections
Virus Diseases

Interventions

BIOLOGICAL: rHPIV3cp45
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]